National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke

Vicky Chalos*, Nadinda A. M. van der Ende, Hester F. Lingsma, Maxim J. H. L. Mulder, Esmee Venema, Simone A. Dijkland, Olvert A. Berkhemer, Albert J. Yoo, Joseph P. Broderick, Yuko Y. Palesch, Sharon D. Yeatts, Yvo B. W. E. M. Roos, Robert J. van Oostenbrugge, Wim H. van Zwam, Charles B. L. M. Majoie, Aad van der Lugt, Bob Roozenbeek, Diederik W. J. Dippel, Olvert A. Berkhemer, Puck S. S. FransenDebbie Beumer, Lucie A. van den Berg, Hester F. Lingsma, Albert J. Yoo, Wouter J. Schonewille, Jan Albert Vos, Paul J. Nederkoorn, Marieke J. H. Wermer, Marianne A. A. van Walderveen, Julie Staals, Jeannette Hofmeijer, Jacques A. van Oostayen, Geert J. Lycklama A. Nijeholt, Jelis Boiten, Patrick A. Brouwer, Bart J. Emmer, Sebastiaan F. de Bruijn, Lukas C. van Dijk, L. Jaap Kappelle, Rob H. Lo, Ewoud J. van Dijk, Joost de Vries, Paul L. M. de Kort, Willem Jan J. van Rooij, Jan S. P. van den Berg, Boudewijn A. A. M. van Hasselt, Leo A. M. Aerden, Rene J. Dallinga, Marieke C. Visser, Joseph C. J. Bot, MR CLEAN Investigators

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)282-290
Number of pages9
JournalStroke
Volume51
Issue number1
DOIs
Publication statusPublished - Jan 2020

Keywords

  • endovascular treatment
  • informed consent
  • NIHSS
  • outcome
  • stroke
  • thrombectomy
  • SURROGATE END-POINTS
  • CLINICAL-TRIALS
  • PLASMINOGEN-ACTIVATOR
  • ENDOVASCULAR THERAPY
  • RANDOMIZED-TRIAL
  • THROMBECTOMY
  • ALTEPLASE
  • SEVERITY

Cite this

Chalos, V., van der Ende, N. A. M., Lingsma, H. F., Mulder, M. J. H. L., Venema, E., Dijkland, S. A., Berkhemer, O. A., Yoo, A. J., Broderick, J. P., Palesch, Y. Y., Yeatts, S. D., Roos, Y. B. W. E. M., van Oostenbrugge, R. J., van Zwam, W. H., Majoie, C. B. L. M., van der Lugt, A., Roozenbeek, B., Dippel, D. W. J., Berkhemer, O. A., ... MR CLEAN Investigators (2020). National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke. Stroke, 51(1), 282-290. https://doi.org/10.1161/STROKEAHA.119.026791